Kazakhstan > Law firm and leading lawyer rankings

Press releases

Press Releases worldwide

• Highlights: ELA Asia Pacific Client Conference

  SyCip Salazar Hernandez & Gatmaitan hosted the  Employment Law Alliance (ELA) Asia Pacific Client Conference  last March 13, 2018. The meeting was attended by 57 representatives from 26 Philippine companies, and by 27 representatives from ELA member firms in China, Guam, Hong Kong, India, Indonesia, Japan, Laos, Malaysia, Myanmar, Philippines, Singapore, Sri Lanka, Taiwan, Thailand, and Vietnam.
  - SyCip Salazar Hernandez & Gatmaitan

• Highlights: Multilaw Asia-Pacific Regional Meeting 2018

  SyCip Salazar Hernandez & Gatmaitan hosted the  Multilaw Asia-Pacific Regional Meeting  last March 12-13, 2018. The meeting was attended by 31 representatives from Multilaw member firms in Australia, China, France, Germany, Indonesia, Japan, Malaysia, Philippines, Singapore, Sri Lanka, Taiwan, Thailand, UK, and Vietnam.
  - SyCip Salazar Hernandez & Gatmaitan

• Bär & Karrer Advised Swiss Re in the Offering of USD 500 Million Senior Exchangeable Notes with Iss

  Swiss Re Ltd (Swiss Re) has completed an offering of USD 500 million, 6-year senior exchangeable notes, which may be stock settled at the option of Swiss Re or may be exchanged at the option of noteholders for registered shares of Swiss Re, unless Swiss Re elects to settle the exchange of notes in cash. Swiss Re has purchased call options on its own shares, which allow it to settle an exchange by noteholders without issuing new shares.
  - Bär & Karrer

• Bär & Karrer Advises Credit Suisse and Bank Berenberg in the IPO of Klingelnberg

  Klingelnberg Ltd, a global leader in developing and manufacturing premium machine tools for bevel gear and cylindrical gear machining and precision measuring centers for gears, successfully priced its IPO and listed its shares on the SIX Swiss Exchange. Trading in the shares started on 20 June 2018. The shares of Klingelnberg were priced at CHF 53 per share, near the upper end of the price range, corresponding to a base offer of CHF 241 million. The offer price implies a market capitalization of approx. CHF 470 million leading to a free float of 56.6% (assuming full exercise of the over-allotment option), whereas the remaining 43.4% remain with the Klingelnberg family as anchor shareholder.
  - Bär & Karrer

• Cederquist Advices on the Acquisition of Veterinary Care Provider AniCura

  Cederquist has represented Mars, Incorporated, in its acquisition of the AniCura group from Nordic Capital Fund VIII and other sellers.
  - Advokatfirman Cederquist

• GOLAW lawyers have been highly recognised by the international peer-review survey Best Lawyers

  GOLAW lawyers have been recognised as the leading professionals in several practices and included in the Ninth Edition of The Best Lawyers in Ukraine 2019. 
  - GOLAW

• Bär & Karrer Advises Summer Capital on the Acquisition of Swiss Education Group

  Summer Capital, an Asia based investment management company, has acquired, by means of an affiliate, all shares of Swiss Education Group Holding AG, the holding company of the SEG group, a leading hospitality management education group that operates several schools in Switzerland.
  - Bär & Karrer

• Prohibited advertising for homeopathic medicinal products featuring promise of success

  The Oberlandesgericht (OLG) München [Higher Regional Court of Munich] has ruled that promoting a homeopathic medicinal product with a promise of success is prohibited and a violation of competition law.
  - GRP Rainer LLP

• VEGAS LEX law firm is sponsor of seminar-conference on matters of regulation of procurement activiti

  8 июня 2018 года юридическая фирма VEGAS LEX совместно с Национальным нефтегазовым форумом и участием ФАС России провела юридический практический семинар на тему «Новые законодательные инициативы и арбитражная практика в регулировании закупочной деятельности».
  - Vegas Lex Law Firm

• Prohibited advertising – No bread roll vouchers at pharmacy

  Pharmacies are bound by a uniform sales price for prescription medications. Even small additions to the price of medicinal products can constitute a violation of competition law.
  - GRP Rainer LLP